AHA publishes playbook to reduce burnout in healthcare

A major healthcare association group has released a playbook to help reduce the prevalence of burnout in the industry. The American Hospital Association has outlined a seven-step approach specifically tailored to health system leaders to address burnout, which is a long-term stress reaction caused by a work environment, according to the association.

Burnout is a pressing issue in the healthcare workforce, with more than 40% of U.S. physicians feeling at least one symptom, such as feelings of depersonalization of exhaustion, according to a recent study. Symptoms can also include a low sense of personal accomplishment. While the burnout can vary by specialty, several healthcare groups have noted that it should be addressed at the institutional level to recapture the joy and purpose of the profession, even creating a culture of wellbeing for physicians, according to the AHA.

Healthcare providers can be deeply impacted by high rates of burnout, with quality and patient safety, the financial burden of replacing burned out employees who quit, and the physical and psychological health consequences of employees all taking a hit. The blueprint notes that a top-down approach isn’t enough to combat the negative effects of burnout and create wellbeing for physicians in the workplace. Instead, all aspects of the health system must be engaged in these efforts, including clinicians, patients and caregivers, regulators and administrators.

Here are the seven steps that AHA came up with to tackle burnout:

Create infrastructure for well-being. With a dedicated budget, executive support and sponsorship from a chief medical officer or CEO, health systems can create infrastructure that cultivates well-being with a wellness team that can champion new initiatives or expand efforts.

Engage your team. Address the stigmas of burnout with a team-based approach, with the wellness team facilitating small group sessions and open-ended surveys to gather feedback.

Measure well-being. Health systems should also be prepared to monitor their own efforts to fight burnout by measuring well-being through benchmark surveys at least annually. Following up with survey participants when issues are raised is also critical.

Design interventions. Engaging the health team and conducting surveys can help identify the top causes of burnout that can be addressed in interventions in the following categories: improving input; increasing recognition; improving quality; improving efficiency; increasing resiliency; cultivating community.

Implement programs. Starting with the easiest implementations, health systems can get their interventions underway and start to build buy-in from employees before moving on to more complex and challenging interventions. Another key focus should be on making these initiatives fun for participants.

Evaluate program impact. One health system may have several underlying causes of burnout, which means one intervention might not make much of a difference. And health systems should continually evaluate if their programs are having an impact, through process metrics and surveys.

Create a sustainable culture. Follow-up feedback is essential for programs to work long term and to expand the success of initial pilots. Celebrate wins “often and loudly,” the playbook urges.

Find the playbook here.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.